Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sophia J. Langlois currently holds 8,390 shares of Keenova Therapeutics plc (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sophia J. Langlois has been a net neutral trader of NONE stock. They have purchased $0 and sold $0 worth of shares.
Sophia J. Langlois's most recent insider trade was on Jul 15, 2026, when they sold 4,406 shares at $0.00 per share.
Sophia J. Langlois serves as Executive at Keenova Therapeutics plc (NONE). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Sophia J. Langlois holds the position of Executive at Keenova Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Sophia J. Langlois has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sophia J. Langlois was on Jul 15, 2026, when they purchased $0 worth of NONE shares. This transaction involved 4,406 shares at N/A per share.
Sophia J. Langlois currently owns 8,390 shares of Keenova Therapeutics plc (NONE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sophia J. Langlois's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sophia J. Langlois has 1 Form 4 filings on record as an insider at Keenova Therapeutics plc.
Set alerts for Sophia J. Langlois and 40,000+ other insiders.